Story type: Institute

  • Hudson News Summer 2024: Director’s message

    Cancer kills three children every week in Australia – more than any other disease. And more than 1,000 children and adolescents are diagnosed with cancer each year – highlighting why our researchers are focused on trying to find much-needed cures and better treatments for children with cancer.…  Read more

    Professor Elizabeth Hartland, Director and CEO of Hudson Institute
  • Prof Hartland named among latest AAHMS Fellows

    The Academy welcomed the new Fellows, which included Hudson Institute Director and CEO, Professor Elizabeth Hartland AM, in a ceremony at its Annual Meeting.…  Read more

    Elizabeth Hartland AM AAHMS Fellow
  • Victoria leads fight against childhood cancer

    At Hudson Institute, Minister for Medical Research Ben Carroll announced the establishment of the Victorian Paediatric Cancer Consortium Limited (VPCC Ltd), made possible by a $35 million investment from the Government and $10 million from the Children’s Cancer Foundation.…  Read more

  • Beischer Foundation sticks its ‘NEC’ out

    Any new parent will tell you how overwhelming it can feel to suddenly be caring for a fragile new life. Now imagine that this life came into the world before it was ready – the fragility is magnified and with it the number of unknowns and things that can go wrong.…  Read more

    Dr Ina Rudloff_Professor Marcel Nold_CEO of Norman Beischer Foundation Andrew Brookes and Professor Claudia Nold
  • Hudson CEO honoured for services to medical research

    Hudson Institute’s Director and CEO, Professor Elizabeth Hartland, is among the recipients of the Order of Australia in the King’s Birthday Honours list, for services to medical research.…  Read more

    Professor Elizabeth Hartland honoured for services to medical research
  • Hudson News Winter 2024: Director’s message

    Every day we are reminded that women’s health conditions don’t receive the funding or priority in medical research that they should. Women are more likely to die from a heart attack, twice as likely to have a hip replacement fail (prosthetic hips have been developed for the male body), more likely to be over medicated (women are frequently excluded from clinical trials) and less likely to have their pain taken seriously.…  Read more

    Professor Elizabeth Hartland, Director and CEO of Hudson Institute
  • Better treatments sooner: Hudson unveils RNAte Platform

    Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.…  Read more

    Natalia Sampaio In the lab of the RNAte Platform at Hudson Institute
  • Inflammation expert welcomed as Centre Head

    Hudson Institute’s world leading inflammation programs enter a new era with the appointment of Professor Seth Masters to lead the Centre for Innate Immunity and Infectious Diseases (CiiiD).…  Read more

    Professor Seth Masters, Centre Head of the Centre for Innate Immunity and Infectious Diseases
  • Hudson News: Summer 2023

    Director’s Message: Changing the odds on ovarian cancer. As medical researchers, we spend a lot of our time looking at numbers, establishing which changes or effects are significant and which are not.…  Read more

    Professor Elizabeth Hartland, Director and CEO of Hudson Institute
  • When stomach cancer survivor becomes expert

    Despite encountering more than her share of health challenges, 92-year-old Delva Walker has the most positive outlook you are ever likely to encounter.…  Read more

    L-R Professor Richard Ferrero, Donor and cancer survivor Delva Walker and Dr Caroline Skene